Abstract
Membranous nephropathy (MN) remains the most common primary cause of nephrotic syndrome in Europe and a common cause of end-stage renal failure. The reporting of anti-phospholipase A2 receptor antibody (PLA2RAb) positivity in 70% of patients with primary MN (PMN) in 2009 was a significant advance in the understanding of the disease pathogenicity.

This publication has 8 references indexed in Scilit: